Cedar-Sinai Medical Center, Samuel Oschin Comprehensive Cancer Institute is a clinical research site located in Los Angeles, California, United States 90048.
Crixeo Health Trust Score: 54/100 (POOR). This profile has not yet been claimed by the site owner.
Cedar-Sinai Medical Center, Samuel Oschin Comprehensive Cancer Institute has participated in 1 clinical trials with 1 currently active.
Therapeutic areas: Small-Cell Lung Cancer, Neuroendocrine Carcinoma.
Sponsors: Harpoon Therapeutics, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA).
Trust Score: 54/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Cedar-Sinai Medical Center, Samuel Oschin Comprehensive Cancer Institute has a Crixeo Trust Score of 54/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Cedar-Sinai Medical Center, Samuel Oschin Comprehensive Cancer Institute has 1 clinical trials on record, with 1 currently active. Their work covers Small-Cell Lung Cancer, Neuroendocrine Carcinoma.
Cedar-Sinai Medical Center, Samuel Oschin Comprehensive Cancer Institute has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.